In the last trading session, 3.16 million BioAffinity Technologies Inc (NASDAQ:BIAF) shares changed hands as the company’s beta touched 3.01. With the company’s per share price at $0.75 changed hands at -$0.06 or -6.83% during last session, the market valuation stood at $11.76M. BIAF’s last price was a discount, traded about -382.67% off its 52-week high of $3.62. The share price had its 52-week low at $0.80, which suggests the last value was -6.67% down since then. When we look at BioAffinity Technologies Inc’s average trading volume, we note the 10-day average is 0.11 million shares, with the 3-month average coming to 154.58K.
BioAffinity Technologies Inc (NASDAQ:BIAF) trade information
Instantly BIAF was in red as seen at the end of in last trading. With action -19.71%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -17.07%, with the 5-day performance at -19.71% in the red. However, in the 30-day time frame, BioAffinity Technologies Inc (NASDAQ:BIAF) is -22.20% down. Looking at the short shares, we see there were 0.27 million shares sold at short interest cover period of 1.43 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -19.28%. The 2025 estimates are for BioAffinity Technologies Inc earnings to increase by 24.18%.
BIAF Dividends
BioAffinity Technologies Inc is expected to release its next quarterly earnings report in February.
BioAffinity Technologies Inc (NASDAQ:BIAF)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 29.55% of BioAffinity Technologies Inc shares while 3.03% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.29%.
